Absence of Serological Evidence of West Nile Virus in Blood Donors in South Western Nigeria
DOI:
https://doi.org/10.52981/sjms.v9i4.1282Keywords:
West Nile virus, blood donors, serological evidence, IgM antibody, NigeriaAbstract
Background: West Nile virus (WNV) is a mosquito-borne virus that circulates among avians, but can also affect other species, particularly humans and horses. The virus is transmissible via blood transfusion. Objectives: To determine the prevalence of the West Nile virus among blood donors in Nigeria.
Materials and Methods: Serum samples from 185 blood donors who donated blood at blood bank units of Obafemi Awolowo University Teaching hospitals and Ladoke Akintola University Teaching Hospital, Nigeria were screened for WNV IgM antibody.
Results: Out of the 185 donors recruited for the study, 175 (94.6%) were males. The age of the participant ranges from 18 – 65 years with the mean age (SD± 20.3). One hundred and sixty five (89.1%) donors are urban dwellers while twenty (10.8%) donors are rural dwellers. Twenty seven donors (15.4%), out of the urban group regularly use insecticides treated or mosquito repellant nets whereas none of the rural dwellers use insecticides or mosquito net. All the 185 donors screened were negative for West Nile virus- specific IgM antibody.
Conclusion: This study reveals that there is no serological evidence of WNV infection in Osun state Nigeria. Although this is only a preliminary report, there would be the need for a more elaborate study cutting across different seasons of the year on the prevalence of WNV in Nigeria
References
2. Smithburn KC, Hughes TP, Burke AW, Paul JH. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med. 1940; 20:471– 92.
3. Taylor RM, Work TH, Hurlbut HS, Rizk F. A study ofthe ecology of West Nile virus in Egypt. Am J Trop Med Hyg.1956; 5: 579 – 620.
4. Olaleye OD, Omilabu SA, Ilomechina EN, Fagbami AH. A survey for haemagglutinationinhibiting antibody to WestNile virus in human and animal sera in Nigeria. Comp ImmunolMicrobiol Infect Dis. 1990;13(1):35-9.
5. Baba M, Logue CH, Oderinde B, Abdulmaleek H, Williams J, Lewis J, Laws TR, Hewson R, Marcello A, D' Agaro P. Evidence of arbovirus coinfection in suspected febrile malaria and typhoid patients in Nigeria. J Infect Dev Ctries. 2013;15:7(1):51-9
6. Hayes, E.B.; Komar, N.; Nasci, R.S.; Montgomery, S.P.; O’Leary, D.R.; Campbell, G.L. Epidemiology and transmission dynamics of West Nile virus disease. Emerging Infect. Dis, 2005; 11, 1167–1173.
7. Michigan ,CDC. Update. Investigation of West Nile Virus Infections in recipients of Organ Transplantation and Blood Transfusion. MMWR 2002; 51:879
8. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003; 349: 1236 – 1245.
9. Blackmore CG, Stark LM, Jeter WC, Oliveri RL, Brooks RG, Conti LA. Surveillance results from the first West Nile virus transmission season in Florida, 2001. Am J Trop Med Hyg. 2003; 69(2):141–5.
10. Tsai, T.F.; Popovici, F.; Cernescu, C.; Campbell, G.L.; Nedelcu, N.I. West Nile encephalitis epidemic in southeastern Romania. Lancet. 1998; 352; 767–771.
11. Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003; 348: 2196 – 2203.
12. Sejvar, J. J., Johnson, D., Popovic, T., Miller, J. M., Downes, F., Weyant, P. R., Stephens, D. S., Perkins, B. A., &Rosentein, N. E. Assessing the Risk of Laboratory-Acquired Meningococcal Disease. Journal of Clinical Microbiology, 2005; 43(9), 4811-4814.
13. Biggerstaff BJ, Petersen LR. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 2003; 43(8):1007–17.
14. Kleinman S, Glynn SA, Busch M, Todd D, Powell L, PietrelliL.The 2003 West Nile virus United States epidemic: the America's Blood Centers experience. Transfusion. 2005; 45:469 – 47
15. Busch MP, Wright DJ, Custer B, Tobler LH, 7StramerSL,Kleinman SH, et al. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis. 2006; 12: 395 – 402.
16. Purdue News. Unpredictable Weather, Disease Carriers Make Protection Paramount. 2005; pp 1- 3.
17. Koopman JS, Prevots DR, Vaca Marin MA, Gomez DantesH,Zarate Aquino ML, Longini IM, Sepulveda Amor J. Determinants and predictors of dengue infection in Mexico.Am J Epi. 1991; 133:1168–1178
18. Baba MM, Saron M, Adeniji JA. The seasonal effect of West Nile Virus in semi-arid zone,Nigeria. Acad. Journal, 2006; 1:31-38
19. Zohreh S, Mahmood M S, Ali T. A Study of West Nile Virus Infection in Iranian Blood Donors Arch Iran Med. 2010; 13 (1): 1 – 4.
20. Koppelman MH, Sjerps MS, de Waal M, Reesink HW, Cuypers HT. No evidence of West Nile virus infection in Dutch blood donors. Vox Sang. 2006; 90: 166 – 169.